Lung cancer working group report

Lung cancer working group report

Asia needs a guideline for non-small-cell lung cancer because of differences in medical care, medical care insurance, ethnic variation and drug approval lag within Asian countries and compared with Western countries. Due to ethnic differences, drug dosages are often higher in the USA than in Japan....

Saved in:

書目詳細資料
Main Authors:	Saijo N., Fukuoka M., Thongprasert S., Ichinose Y., Mitsudomi T., Mok T., Ohe Y., Park K., Wu Y.
格式:	雜誌
出版:	2017
在線閱讀:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77957280882&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/43250
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!
機構:	Chiang Mai University

相似書籍

Lung cancer working group report
由: Nagahiro Saijo, et al.
出版: (2018)

Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study
由: Wu Y.-L., et al.
出版: (2014)

Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non - small-cell lung cancer in Asia (IPASS)
由: Fukuoka M., et al.
出版: (2017)

Gefitinib or Erlotinib vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall Survival
由: Lee C., et al.
出版: (2017)

Lung cancer and quality of life
由: Thongprasert S.
出版: (2014)

Lung cancer in Maharaj Nakorn Chiang Mai Hospital: Comparison of the clinical manifestations between the young and old age groups
由: Deesomchok A., et al.
出版: (2014)

Efficacy according to blind independent central review: Post-hoc analyses from the phase III, randomized, multicenter, IPASS study of first-line gefitinib versus carboplatin/paclitaxel in Asian patients with EGFR mutation-positive advanced NSCLC
由: Wu Y., et al.
出版: (2017)

Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study
由: Yi Long Wu, et al.
出版: (2018)

Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study
由: Yi Long Wu, et al.
出版: (2018)

Lung cancer in Maharaj Nakorn Chiang Mai Hospital: Comparison of the clinical manifestations between the young and old age groups
由: Athavudh Deesomchok, et al.
出版: (2018)

Phase II study of ifosfamide, carboplatin, etoposide and GM-CSF in small cell lung cancer
由: Thongprasert S.
出版: (2014)

Gefitinib or Erlotinib vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall Survival
由: Chee Khoon Lee, et al.
出版: (2018)

Gefitinib or Erlotinib vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall Survival
由: Chee Khoon Lee, et al.
出版: (2018)

Ifosfamide, epirubicin and cisplatin (IEP): another active combination for small cell lung cancer (SCLC)
由: Thongprasert S., et al.
出版: (2014)

Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer)
由: Nokihara, H, et al.
出版: (2022)

Phase II study of paclitaxel (Taxol) and ifosfamide (Holoxan) in inoperable non-small-cell lung cancer
由: Thongprasert S.
出版: (2014)

Genetic variants associated with longer telomere length are associated with increased lung cancer risk among never-smoking women in Asia: A report from the female lung cancer consortium in Asia
由: Machiela, M.J., et al.
出版: (2016)

Efficacy and tolerability of tropisetron in the prevention of cisplatin-induced nausea and vomiting in advanced non-small cell lung cancer
由: Thongprasert S.
出版: (2014)

Combination of gemcitabine and cisplatin in advanced non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Docetaxel as second-line chemotherapy for advanced non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Lung Cancer Screening in Asia: An Expert Consensus Report
由: Lam D.C.L.
出版: (2023)

Analysis of the four combination chemotherapies in non-small cell lung cancer treated at Maharaj Nakorn Chiang Mai Hospital
由: Thongprasert S.
出版: (2014)

Preliminary study of efficacy of intravenous cisplatin plus oral etoposide in small cell lung cancer
由: Chewaskulyong B., et al.
出版: (2014)

Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non - small-cell lung cancer in Asia (IPASS)
由: Masahiro Fukuoka, et al.
出版: (2018)

Treatment of small cell lung cancer: experience at Maharaj Nakhon Chiang Mai Hospital
由: Thongprasert S., et al.
出版: (2014)

Biomass fuels and lung cancer
由: Lim, W.-Y., et al.
出版: (2014)

Phase II study of three days' fractionated dosage of ifosfamide, epirubicin and cisplatin in small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Study of cisplatin-vinblastine plus amifostine in patients with locally advanced or metastatic non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Risk of second cancer from scattered radiation of intensity-modulated radiotherapies with lung cancer
由: Kim D.W., et al.
出版: (2018)

Usefulness of the Thai modified functional living index--cancer (T-FLIC) and the Thai modified quality of life index (T-QLI) for advanced non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

The breast cancer working group presentation was divided into three sections: The epidemiology, pathology and treatment of breast cancer
由: Toi, M., et al.
出版: (2014)

Paclitaxel and carboplatin plus megestrol acetate in the treatment of advanced non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Crizotinib treatment for advanced non-small-cell lung cancer patients: a budget impact analysis based in Thailand
由: Thongprasert S., et al.
出版: (2017)

Treatment of advanced non-small cell lung cancer with vinorelbine in elderly Thai patients
由: Sorraritchingchai S., et al.
出版: (2014)

Incidence rates of specific histological types of lung cancer in Singapore Chinese dialect groups, and their aetiological significance
由: Law, C.H., et al.
出版: (2016)

Acute gastroenteritis disease: Report of the FISPGHAN working group
由: Guarino, A., et al.
出版: (2016)

Sarcopenia in Asia: Consensus report of the Asian working group for sarcopenia
由: Liang Kung Chen, et al.
出版: (2018)

Epidemiology of Lung Cancer in Women
由: Wu, A.H., et al.
出版: (2014)

Improving the results of small cell lung cancer.
由: Tan, Y.O.
出版: (2014)

Crizotinib treatment for advanced non-small-cell lung cancer patients: a budget impact analysis based in Thailand
由: Sumitra Thongprasert, et al.
出版: (2018)